Medistem Inc. is a biotechnology company founded to develop and commercialize technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. Our lead product, the endometrial regenerative cell (ERC), is a “universal donor” stem cell derived from menstrual blood that possesses the ability to differentiate into nine tissue types, produces large quantities of growth factors, and has a large proliferative capacity.
To learn more about MediStem, use the links below. Also, check out our News Room.